GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA
GeoVax chairman, president, and CEO David A. Dodd Can GeoVax Labs’ dual-antigen COVID-19 vaccine succeed where leading messenger RNA (mRNA)-based ...
Home » biontech
GeoVax chairman, president, and CEO David A. Dodd Can GeoVax Labs’ dual-antigen COVID-19 vaccine succeed where leading messenger RNA (mRNA)-based ...
The FDA has imposed a partial clinical hold on the Phase I trial of an antibody-drug conjugate (ADC) cancer therapy ...
President Joe Biden and former President Donald Trump have seemingly found one issue they can agree on: Drug costs are ...
SAN DIEGO—With plans to advance 10 drugs into the clinic over the next five years for a variety of disorders, ...
Explore the synergy of chemistry and technology with ChemTech Digest. Dive into the latest research, tech advancements, and scientific discoveries shaping our world.
Copyright 2024 © All Rights Reserved. ChemTech Digest | SiteMap